Search

3i Group PLC

Slēgts

SektorsIndeksi

2,299 0.57

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

2298

Max

2324

Galvenie mērījumi

By Trading Economics

Ienākumi

-1.3B

2B

Pārdošana

44M

236M

P/E

Sektora vidējais

4.295

19.461

EPS

3.4

Dividenžu ienesīgums

3.66

Peļņas marža

850.424

Darbinieki

223

EBITDA

-745M

2B

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+36.98% upside

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

3.66%

3.47%

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-1.3B

24B

Iepriekšējā atvēršanas cena

2298.43

Iepriekšējā slēgšanas cena

2299

Ziņu noskaņojums

By Acuity

52%

48%

16 / 26 Rangs Indices

3i Group PLC Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 14. maijs 08:38 UTC

Peļņas
Galvenie tirgus virzītāji

3i Group Shares Plunge After Slowdown at Retailer Action

2026. g. 29. janv. 16:27 UTC

Galvenie tirgus virzītāji

U.K. Private Equity Group 3i's Shares Surge on Strong Sales at Key Asset

2025. g. 13. nov. 10:02 UTC

Peļņas
Galvenie tirgus virzītāji

3i Group Shares Tumble After Cautious Outlook

2026. g. 14. maijs 09:08 UTC

Tirgus saruna
Peļņas

3i Group Suffers as Problems Mount at Retailer Action -- Market Talk

2026. g. 14. maijs 07:04 UTC

Tirgus saruna
Peļņas

3i Group Buyback Might Be Eclipsed by Concerns on Key Holding Action -- Market Talk

2026. g. 14. maijs 06:07 UTC

Peļņas

3i Group: Private Equity Business Delivered Gross Investment Return of GBP5.30B in FY26

2026. g. 14. maijs 06:06 UTC

Peļņas

3i Group: Action Remained Significant Driver of Group's Performance in FY26

2026. g. 14. maijs 06:05 UTC

Peļņas

3i Group: FY2026 Total Return of GBP5.30B

2026. g. 14. maijs 06:05 UTC

Peļņas

3i Group Received GBP1.9B of Cash Proceeds From Portfolio in FY 2026

2026. g. 14. maijs 06:04 UTC

Peļņas

3i Group: Expect to See an Increase in Inflation Over Coming Months

2026. g. 14. maijs 06:04 UTC

Peļņas

3i Group: Market Environment Remains Complex Due to Middle East Situation

2026. g. 14. maijs 06:03 UTC

Peļņas

3i Group Declares Second Interim Dividend of 48p a Share

2026. g. 14. maijs 06:02 UTC

Peļņas

3i Group Plans Buyback of Up to GBP750M

2026. g. 14. maijs 06:00 UTC

Peļņas

3i FY Pretax Pft GBP5.29B

2026. g. 14. maijs 06:00 UTC

Peļņas

3i FY NAV/Shr GBP30.30

2026. g. 14. maijs 06:00 UTC

Peļņas

3i FY Net Pft GBP5.29B

2026. g. 14. maijs 06:00 UTC

Peļņas

3i FY EPS GBP5.386

2026. g. 26. marts 14:12 UTC

Tirgus saruna
Galvenie ziņu notikumi

Action, 3i Group's Flagship Holding, Suffers from Bleak Outlook for Discount Retailers -- Market Talk

2026. g. 29. janv. 14:18 UTC

Tirgus saruna
Peļņas

3i Group's Value Proposition Built on Discount Retailer -- Market Talk

2026. g. 29. janv. 08:47 UTC

Tirgus saruna
Peļņas

3i Faces Tough Conditions in France, Competition from Chinese E-Tailers -- Market Talk

2026. g. 29. janv. 07:06 UTC

Peļņas

3i Group Gross Cash at Dec. 31 GBP995M

2026. g. 29. janv. 07:04 UTC

Peļņas

3i Group: Action Gross Cash at Dec. 31 Was EUR807M

2026. g. 29. janv. 07:02 UTC

Peļņas

3i Group: Action LFL Sales Up 6.1% in First Four Weeks of Jan

2026. g. 29. janv. 07:01 UTC

Peļņas

3i Group: Action's Like-For-Like Sales Growth Was 4.9%

2026. g. 29. janv. 07:01 UTC

Peļņas

3i Group: Action Net Sales, Operating Ebitda Rose 16% and 14%

2026. g. 29. janv. 07:00 UTC

Peļņas

3i Group NAV Per Shr Rose to 3,017 Pence

2025. g. 13. nov. 07:29 UTC

Peļņas

3i Group: First Div Is Set at 50% of Total Div for FY2025

2025. g. 13. nov. 07:29 UTC

Peļņas

3i Group PLC Declares Dividend of 36.5p

2025. g. 13. nov. 07:28 UTC

Peļņas

3i Group Had Net Debt of GBP772M, Gearing of 3%

2025. g. 13. nov. 07:28 UTC

Peļņas

3i Group Ended Period With Liquidity of GBP1.64B

3i Group PLC Prognoze

Cenas mērķis

By TipRanks

36.98% augšup

Prognoze 12 mēnešiem

Vidējais 3,105.33 GBX  36.98%

Augstākais 4,280 GBX

Zemākais 1,850 GBX

Pamatojoties uz 6 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi 3i Group PLC — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

6 ratings

4

Pirkt

0

Turēt

2

Pārdot

Noskaņojums

By Acuity

16 / 26 Rangs Indeksi

Ziņu noskaņojums

Liecība "Lāču" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par 3i Group PLC

3i Group plc is a private equity firm specializing in mature companies, growth capital, middle markets, infrastructure, and management leveraged buyouts and buy-ins. The firm also provides infrastructure financing and debt management. For debt management, it invests in senior and mezzanine corporate debt in typically large and private companies in United Kingdom, Europe, Asia, and North America. It makes private equity investments in business and technology services, financial services, consumer, healthcare, consumption and distribution, media and telecom, renewable energy, wind, and industrial technology sector. Within business and technology services, the firm seeks to invest in sub sectors such as testing, inspection and certification; intelligent outsourcing, BPO and consultancy; human capital including staffing, governance, risk and compliance, services to pharmaceutical companies, vertical application software, education and training businesses; facilities management; support services to industrial sectors such as oil and gas and utilities; human resources outsourcing and advising; recruitment; logistics and infrastructure support services including distribution, waste, and rental. In the consumer sector, it focuses on, multi-unit roll out, omni-channel propositions, niche branded consumer goods, polarization, health and wellness, ageing population, millennials, consumer goods; e-commerce; retail; food and drinks; and leisure. In the healthcare sector, the firm focuses on outsourced medical device manufacturing & services, outsourced pharmaceutical manufacturing & services, bioprocessing supply chain, life science tools and diagnostics, wellness & consumer health products, pharmaceuticals and biotechnology including specialty pharma, generics / OTC, drug delivery, and animal health; healthcare Services including activities such as elderly and specialty care, including caring for people in their own homes, in hospital and in community facilities, as well as operational services such as outsourced support, cl
help-icon Live chat